| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AB04) | Adalimumab | 2519 | |
| PURCH | PURCH_ATC(L04AB01) | Etanercept | 1912 | |
| PURCH | PURCH_ATC(L04AB06) | Golimumab | 950 | |
| PURCH | PURCH_ATC(L04AB05) | Certolizumab pegol | 479 | |
| PURCH | PURCH_ATC(L04AC10) | Secukinumab | 399 | |
| PURCH | PURCH_ATC(L04AA24) | Abatacept | 393 | |
| PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 368 | |
| PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 256 | |
| PURCH | PURCH_ATC(L04AC03) | Anakinra | 37 |